H Berna Beverloo

8PUBLICATIONS
80CO-AUTHORS
Medical mycologyPredictive and prognostic markersHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Infant and child health
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Feb 24, 2026
MDS/AML and AML with myelodysplasia-related gene mutations: clinical and molecular similarities.

Emma L Boertjes, Tim Grob, Adil Al Hinai

|Jan 13, 2026
MDS/AML and AML with myelodysplasia-related gene mutations: clinical and molecular similarities.

Emma L Boertjes, Tim Grob, Adil Al Hinai

|Oct 08, 2025
MECOM is a master repressor of myeloid differentiation through dose control of CEBPA in acute myeloid leukemia.

Dorien Pastoors, Marije Havermans, Roger Mulet-Lazaro

|May 22, 2025
A revised prognostic model for patients with acute myeloid leukemia and first relapse.

Niek G van der Maas, Dimitri Breems, Clara P W Klerk

|Sep 04, 2024
Risk Stratification in Older Intensively Treated Patients With AML.

Jurjen Versluis, Marlen Metzner, Ariel Wang

|Nov 30, 2023
Bosutinib in Resistant and Intolerant Pediatric Patients With Chronic Phase Chronic Myeloid Leukemia: Results From the Phase I Part of Study ITCC054/COG AAML1921.

Erica Brivio, Edoardo Pennesi, Marieke E Willemse

Pageof 2

Frequent Collaborators

4 joint publications

Bob Löwenberg

3 joint publications

Emma L Boertjes

3 joint publications

Tim Grob

3 joint publications

Claudia A J Erpelinck-Verschueren